BRS2(FM1) - Methylation Cycle Efficiency
(One-Carbon Methylation & Homocysteine Recycling)
1. Mission & Overview
Mission
Sustain efficient one-carbon cycling so homocysteine is cleared, SAMe remains available, and methylation capacity supports brain-relevant chemistry.
Overview
Supports the body's ability to recycle homocysteine (a sulfur amino acid that rises when one-carbon metabolism is strained), produce SAMe (S-adenosylmethionine, the body's universal methyl donor), and sustain methylation capacity across neurotransmitter synthesis, membrane chemistry, and gene regulation. Efficient one-carbon cycling is a foundation for many brain-relevant processes.
- Sustains neurotransmitter synthesis and monoaminergic pathway support — Supporting BRS1.
- Helps control homocysteine-linked oxidative and inflammatory burden — Supporting BRS3.
- Supports mitochondrial function, epigenetic regulation, and cellular repair — Supporting BRS4.
2. Primary Biological Effects
↑ SAMe availability; ↓ homocysteine; ↑ methylation capacity
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Medium
- Synthesis: Integrated methylation cycle efficiency — folate/B12 remethylation, betaine/BHMT parallel routing, SAMe synthesis, and cycle flux — sustains methyl-donor pools required for phospholipid, neurotransmitter, and broader methylation chemistry relevant to cognitive clarity. Homocysteine as a cycle-throughput marker and B-vitamin × omega-3 nutrient-network interactions (VITACOG) support convergent translational framing; this scores biological relevance within BRAIN, not dietary treatment efficacy. Evidence Confidence is low-medium because attached refs establish one-carbon biochemistry and cognitive-decline interaction more than direct ADHD cognitive-clarity outcomes on this integrated FM.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Coordinated one-carbon cycling — homocysteine remethylation cofactor sufficiency, methyl-donor pattern coverage, and cycle flux — intersects ADHD-relevant disturbances in folate, B12, and homocysteine reported across paediatric cohorts and dietary-pattern analyses. MTHFR variation and unhealthy dietary patterns linked to lower B vitamins reinforce modifiable nutritional context for attention-relevant methylation biology without single-nutrient treatment claims.
- Key References:
- Razavinia et al. (2024)
- Lukovac et al. (2024)
- Wang et al. (2019) — Human Study
- Millichap and Yee (2012)
- Evidence Confidence: Low–Medium
4. Mechanistic Basis (Integrated FM Narrative)
Methylation cycle efficiency emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
-
BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation Maintains the body's methylation capacity by recycling homocysteine back into methionine through folate- and vitamin B12-dependent remethylation (the primary one-carbon route for clearing homocysteine).
-
BRS2-FM1-PM2 — Betaine/BHMT Remethylation Provides a parallel route for clearing homocysteine and keeping methyl donors available when folate-pathway demands are high or constrained, via betaine-dependent remethylation through the BHMT enzyme (betaine–homocysteine methyltransferase).
-
BRS2-FM1-PM3 — SAMe Synthesis Converts regenerated methionine into SAMe (S-adenosylmethionine, the body's universal methyl donor), powering methylation reactions across brain and body.
-
BRS2-FM1-PM4 — Methionine Cycle Flux Reflects how efficiently the whole methionine cycle runs — affecting homocysteine levels, SAMe output, and overall methylation capacity across the system.
4.2 Integrated Functional Narrative
Together, folate/B12 remethylation, betaine-dependent BHMT recycling, SAMe synthesis, and methionine-cycle flux operationalise BRS2(FM1) as a coordinated one-carbon methylation control point.
At the integrated FM level, elevated homocysteine is interpreted as a marker of impaired one-carbon cycling, while dietary patterns supplying methyl donors, sulfur amino acids, and supportive omega-3 context may help support homocysteine modulation and overall methylation capacity [Collaboration, 1998; Tao Huang et al., 2015; Oulhaj et al., 2016].
4.3 Suboptimal Function & Its Effects
Methylation cycle efficiency may weaken when one-carbon donor pools or methionine/transsulfuration substrate pools become chronically inadequate.
Low intake of methyl-donor-rich foods may reduce BRS2(KC1) — One-Carbon Donor Pool. Poor dietary choline availability, low folate availability, increased methylation demand, and impaired remethylation efficiency may further strain donor-pool support across daily meal patterns.
Low protein quality or insufficient sulfur-amino-acid intake may reduce BRS2(KC2) — Methionine & Transsulfuration Substrate Pool. Chronic methionine substrate insufficiency, increased glutathione demand, and oxidative burden driving sulfur-amino-acid utilisation may further compromise cycle throughput.
These pressures may impair BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation, weaken BRS2-FM1-PM2 — Betaine/BHMT Remethylation, reduce the effectiveness of BRS2-FM1-PM3 — SAMe Synthesis, and compromise BRS2-FM1-PM4 — Methionine Cycle Flux. At the FM level, this may shift BRS2(FM1) toward reduced methylation cycle efficiency.
4.4 Evidence Highlights
Introduction/Summary
The studies below support methylation cycle efficiency as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: A meta-analysis of folic-acid supplementation trials found that folate typically lowers plasma homocysteine by approximately 25%; adding B12 produced an additional ~7% reduction beyond folate alone → [Collaboration, 1998] This supports interpreting homocysteine modulation as a cofactor-combination property — folate and B12 are not fully interchangeable in remethylation support.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In a randomised trial comparing vitamin B-12, fish oil, and combined B-12 + fish oil, plasma homocysteine fell by 22%, 19%, and 39% respectively — the combined arm nearly doubling the B-12-alone effect → [Tao Huang et al., 2015] This finding supports reading remethylation alongside connected membrane biology rather than as an isolated B-vitamin pathway.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Low-dose betaine supplementation produced immediate and sustained lowering of plasma homocysteine in healthy adults, supporting betaine as a dietary methyl-donor lever for homocysteine modulation → [Olthof et al., 2003]
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In a randomised trial, vitamin B-12 alone lowered homocysteine by 22%, fish oil by 19%, and combined B-12 + fish oil by 39% — illustrating that remethylation support interacts with connected nutrient pathways beyond a single methyl-donor route → [Tao Huang et al., 2015] For BHMT, the parallel implication is that homocysteine clearance is best read across multiple remethylation and connected pathways rather than through betaine alone.
- Key References:
5. Connected Mechanisms
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support — SAMe-dependent PEMT methylation
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation — neuronal Membrane DHA Incorporation
- BRS2-FM2-PM5 — Transsulfuration Pathway — transsulfuration Pathway
- BRS2-FM3-PM7 — Phosphatidylcholine Formation — phosphatidylcholine Formation
- BRS2(FM3) — Methylation–Membrane Coupling — methylation–Membrane Coupling
6. References
- Collaboration (1998) — Lowering Blood Homocysteine with Folic Acid Based Supplements
- Tao Huang et al. (2015) — A Randomized Controlled Trial
- Oulhaj et al. (2016) — Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B
- Luzzi et al. (2022) — State of the Art
- Chiang et al. (1996) — S-Adenosylmethionine and Methylation
- Razavinia et al. (2024) — Vitamins B ₉ and B ₁₂ in Children with Attention Deficit Hyperactivity
- Lukovac et al. (2024) — Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels
- Wang et al. (2019) — Path Analysis for a Case-Control Study
- Millichap and Yee (2012) — Diet Factor in Attention-Deficit/Hyperactivity Disorder